News & Updates

Show Multimedia Only
Can atorvastatin save COVID-19 patients in intensive care?

Can atorvastatin save COVID-19 patients in intensive care?

18 Jan 2022 byStephen Padilla

Use of atorvastatin in adults with COVID-19 admitted to the intensive care unit (ICU) is safe but does not result in a marked decrease in the composite of venous or arterial thrombosis, treatment with extracorporeal membrane oxygenation, or all-cause mortality, a study has shown.

18 Jan 2022
Side effects from COVID-19 vaccines short-lived, vary according to age, sex

Side effects from COVID-19 vaccines short-lived, vary according to age, sex

18 Jan 2022 byTristan Manalac

Vaccines against the coronavirus disease 2019 (COVID-19) often cause temporary disturbances in cardiovascular, respiratory, and sleep physiology, according to a new study. Moreover, such perturbations can be detected by wearable devices.

18 Jan 2022
SARS-CoV-2 pneumonia more deadly than bacteraemic pneumococcal pneumonia

SARS-CoV-2 pneumonia more deadly than bacteraemic pneumococcal pneumonia

18 Jan 2022

Bacteraemic pneumococcal community-acquired pneumonia is associated with higher disease severity and frequent intensive care unit admission, as reported in a study. However, SARS-CoV-2-related pneumonia poses a greater mortality risk.

18 Jan 2022
Sex-specific prediction models help estimate pancreatic ductal adenocarcinoma risk in diabetes

Sex-specific prediction models help estimate pancreatic ductal adenocarcinoma risk in diabetes

18 Jan 2022

The risk of pancreatic ductal adenocarcinoma (PDAC) appears to be higher among individuals with diabetes than in the general population, as well as in men than women, according to a study. Prediction models built around this finding demonstrate moderate accuracy for pinpointing men at high risk of PDAC, in whom surveillance may be required.

18 Jan 2022